CA
NZ
UK
AU
IND
US
JPMorgan Chase Financial Company LLC has introduced a new structured investment product designed to offer investors early exit opportunities at a premium or uncapped upside exposure to equity market performance. The Auto Callable Accelerated Barrier Notes, due July 31, 2031, are linked to the …
Chinese titanium manufacturers are strategically expanding their reach into the aerospace sector, a move that could alter the competitive environment of the global titanium market. By targeting international markets, these firms aim to reduce their dependence on domestic sales, which have historically dominated their …
Molina Healthcare, Inc. (NYSE: MOH) has unveiled second-quarter 2026 results, reporting an adjusted earnings per share (EPS) of $1.51, which outpaced analysts’ expectations of $1.40. The performance reflects ongoing adjustments within the Medicaid and Medicare segments, signaling a strategic positioning as the company navigates …
NewAmsterdam Pharma Co N.V. Is undergoing a significant leadership change as Chief Operating Officer Mr. Kling announces his resignation, effective August 14, 2026.
Serina Therapeutics, Inc. (NYSE American: SER) announced that Farrell Simon, Pharm.D. Has been appointed to its Board of Directors, with his service beginning in July 2026. Simon will serve on both the Audit Committee and the Compensation Committee, providing the board with additional depth …
Swedencare AB (publ) unveiled its second-quarter results for 2026, revealing a substantial miss in earnings expectations. The company posted earnings per share of $0.11 for the quarter, falling short of analyst estimates, which were set at $0.20. This disparity highlights ongoing challenges for the …
Tempest Therapeutics, Inc. (NASDAQ: TPST) has announced a significant collaboration agreement with Hebei Senlang Biotechnology Co. Ltd. to develop its proprietary TPST-4003 product candidate. This partnership marks a critical step for Tempest as it seeks to advance its innovative CAR-T cell therapy for treating …
GS Finance Corp., guaranteed by The Goldman Sachs Group, Inc., has filed a preliminary pricing supplement for a new equity-linked notes offering maturing in 2031. The autocallable contingent coupon notes are tied to the common stock of Apple Inc., Meta Platforms, Inc., and NVIDIA …
Galderma, a prominent player in the aesthetic treatment industry, has observed a marked increase in demand for Botox, attributed to the effects of the so-called "Ozempic face" phenomenon. As the use of GLP-1 medications rises, which are known for weight loss but can lead …
Keros Therapeutics, Inc. (NASDAQ: KROS) is managing a key leadership shift as its Chief Financial Officer, Keith Regnante, departs effective early August 2026. The exit coincides with a period of heightened market pressure, during which the company’s share price has trended downward. Annita Tanini, …
Please wait processing your request...